Frontiers | Case Report: Liraglutide for Weight Management in Beckwith-Wiedemann Syndromic Obesity | Endocrinology
Nanotechnology advances towards development of targeted-treatment for obesity | Journal of Nanobiotechnology | Full Text
Understanding the Mechanism of Action and Clinical Implications of Anti- Obesity Drugs Recently Approved in Korea
Neural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist - Katsurada - 2016 - Journal of Diabetes Investigation - Wiley Online Library
Existing and Emerging Molecular Targets for the Pharmacotherapy of Obesity - Endotext - NCBI Bookshelf
Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss - Gastrointestinal Endoscopy
Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect
Pharmacotherapy of obesity: Available medications and drugs under investigation - Metabolism - Clinical and Experimental
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? | SpringerLink
Diabetes & Metabolism Journal
Proposed mechanism of action of liraglutide on rat lung tissues.:... | Download Scientific Diagram
Liraglutide – Next-Generation Antidiabetic Medication - Clinical Trials Arena
Biomolecules | Free Full-Text | Obesity–An Update on the Basic Pathophysiology and Review of Recent Therapeutic Advances | HTML
Saxenda (liraglutide) for the Treatment of Obesity - Clinical Trials Arena
Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists in: Journal of Endocrinology Volume 236 Issue 1 (2018)
GLP1 receptor agonism protects against acute olanzapine-induced hyperglycemia | American Journal of Physiology-Endocrinology and Metabolism
Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension | Arteriosclerosis, Thrombosis, and Vascular Biology
![SAXENDA (liraglutide [rDNA origin] injection) - Renal and Urology News](https://www.renalandurologynews.com/wp-content/uploads/sites/22/2019/01/saxendaslide981_705533.jpg "SAXENDA (liraglutide [rDNA origin] injection) - Renal and Urology News")
SAXENDA (liraglutide [rDNA origin] injection) - Renal and Urology News
The 10+ Benefits of Liraglutide — MyBioHack | Unlock Your Maximus Potential
The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways | JACC: Basic to Translational Science
Liraglutide and Cardiovascular Risk Factors in Diabetes
Mechanism of action summary of FDA-approved, longterm anti-obesity... | Download Scientific Diagram
The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg | Diabetology & Metabolic Syndrome | Full Text
Frontiers | GLP-1 based therapeutics: simultaneously combating T2DM and obesity | Neuroscience
